SCHEMBL22216433

SCHEMBL22216433

CC/C(=C\F)Cn1cc(C(=O)O)cn1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.56
PLA2G4A P47712 1/20 0.42
ACHE P22303 4/20 0.38
ALKBH2 Q6NS38 2/20 0.36
HPGDS O60760 1/20 0.36
EGLN1 Q9GZT9 6/20 0.35
HSD17B10 Q99714 1/20 0.35
ALKBH1 Q13686 1/20 0.34
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C19 P33261 1/20 0.33
GFER P55789 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALPI P09923 1/20 0.33
ALPG P10696 1/20 0.33
PLAA Q9Y263 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23907231 0.85 L3MBTL1 (0.49) L3MBTL1PLA2G4AACHEALKBH2HPGDS
SCHEMBL23907233 0.85 L3MBTL1 (0.49) L3MBTL1PLA2G4AACHEALKBH2HPGDS
SCHEMBL22216435 0.85 L3MBTL1 (0.39) L3MBTL1ACHECCNCCDK8LMNA
SCHEMBL23920716 0.85 HPGD (0.40) L3MBTL1PLA2G4AACHELMNAMAPT
SCHEMBL22216455 0.83 LMNA (0.42) L3MBTL1ACHELMNAMAPTCYP2C19
SCHEMBL22216190 0.82 AOC3 (0.42) L3MBTL1ACHELMNAMAPTCYP2C19
SCHEMBL23907175 0.77 KMT2A (0.45) L3MBTL1ALKBH2HPGDSEGLN1MAPT
SCHEMBL23907174 0.77 KMT2A (0.45) L3MBTL1ALKBH2HPGDSEGLN1MAPT
SCHEMBL22216318 0.77 LMNA (0.51) L3MBTL1LMNAMAPTCYP2C19GFER
SCHEMBL23907153 0.77 L3MBTL1 (0.41) L3MBTL1PLA2G4AACHEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892621-A1 HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF Nanjing Transthera Biosciences Co., Ltd. (CN) 2021-10-13 EP disclosed
WO-2020143763-A1 HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF 南京药捷安康生物科技有限公司 2020-07-16 WO disclosed